• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFIT2缺失促进口腔癌中癌症干细胞样表型

IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer.

作者信息

Lai Kuo-Chu, Regmi Prabha, Liu Chung-Ji, Lo Jeng-Fan, Lee Te-Chang

机构信息

Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.

Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.

出版信息

Biomedicines. 2023 Mar 14;11(3):896. doi: 10.3390/biomedicines11030896.

DOI:10.3390/biomedicines11030896
PMID:36979874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045464/
Abstract

(1) Background: Cancer stem cells (CSCs) are a small cell population associated with chemoresistance, metastasis and increased mortality rate in oral cancer. Interferon-induced proteins with tetratricopeptide repeats 2 (IFIT2) depletion results in epithelial to mesenchymal transition, invasion, metastasis, and chemoresistance in oral cancer. To date, no study has demonstrated the effect of IFIT2 depletion on the CSC-like phenotype in oral cancer cells. (2) Methods: Q-PCR, sphere formation, Hoechst 33,342 dye exclusion, immunofluorescence staining, and flow cytometry assays were performed to evaluate the expression of the CSC markers in IFIT2-depleted cells. A tumorigenicity assay was adopted to assess the tumor formation ability. Immunohistochemical staining was used to examine the protein levels of IFIT2 and CD24 in oral cancer patients. (3) Results: The cultured IFIT2 knockdown cells exhibited an overexpression of ABCG2 and CD44 and a downregulation of CD24 and gave rise to CSC-like phenotypes. Clinically, there was a positive correlation between IFIT2 and CD24 in the patients. IFIT2/CD24/CD44 expression profiles predicted a better prognosis in HNC, including oral cancer. The TNF-α blockade abolished the IFIT2 depletion-induced sphere formation, indicating that TNF-α may be involved in the CSC-like phenotypes in oral cancer. (4) Conclusions: The present study demonstrates that IFIT2 depletion promotes CSC-like phenotypes in oral cancer.

摘要

(1) 背景:癌症干细胞(CSCs)是一小部分与口腔癌的化疗耐药性、转移及死亡率增加相关的细胞群体。干扰素诱导的四肽重复序列蛋白2(IFIT2)缺失会导致口腔癌发生上皮-间质转化、侵袭、转移及化疗耐药。迄今为止,尚无研究证实IFIT2缺失对口腔癌细胞中癌症干细胞样表型的影响。(2) 方法:进行定量聚合酶链反应(Q-PCR)、成球实验、Hoechst 33342染料排除实验、免疫荧光染色及流式细胞术分析,以评估IFIT2缺失细胞中癌症干细胞标志物的表达。采用致瘤性实验评估肿瘤形成能力。免疫组织化学染色用于检测口腔癌患者中IFIT2和CD24的蛋白水平。(3) 结果:培养的IFIT2基因敲低细胞表现出ABCG2和CD44的过表达以及CD24的下调,并产生癌症干细胞样表型。临床上,患者中IFIT2和CD24之间存在正相关。IFIT2/CD24/CD44表达谱预测包括口腔癌在内的头颈部癌预后较好。肿瘤坏死因子-α(TNF-α)阻断消除了IFIT2缺失诱导的成球现象,表明TNF-α可能参与口腔癌的癌症干细胞样表型。(4) 结论:本研究表明IFIT2缺失促进口腔癌中的癌症干细胞样表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/8a3e6bb467e9/biomedicines-11-00896-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/8ae97e00cb50/biomedicines-11-00896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/d3c549473da7/biomedicines-11-00896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/ee5a99643c85/biomedicines-11-00896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/06642404a3f5/biomedicines-11-00896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/8a3e6bb467e9/biomedicines-11-00896-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/8ae97e00cb50/biomedicines-11-00896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/d3c549473da7/biomedicines-11-00896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/ee5a99643c85/biomedicines-11-00896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/06642404a3f5/biomedicines-11-00896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d154/10045464/8a3e6bb467e9/biomedicines-11-00896-g005.jpg

相似文献

1
IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer.IFIT2缺失促进口腔癌中癌症干细胞样表型
Biomedicines. 2023 Mar 14;11(3):896. doi: 10.3390/biomedicines11030896.
2
Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells.阻断 TNF-α 抑制 IFIT2 缺失的转移性口腔鳞状细胞癌细胞的血管生成和生长。
Cancer Lett. 2016 Jan 28;370(2):207-15. doi: 10.1016/j.canlet.2015.10.016. Epub 2015 Oct 27.
3
Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.耗尽 IFIT2 通过非典型 PKC 信号转导增强口腔鳞状细胞癌细胞的迁移和转移活性。
Oncogene. 2013 Aug 8;32(32):3686-97. doi: 10.1038/onc.2012.384. Epub 2012 Sep 17.
4
CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.CD44(高表达)CD24(低表达)分子特征决定口腔鳞状细胞癌中的癌症干细胞和上皮-间质转化表型。
Stem Cell Res. 2016 Mar;16(2):405-17. doi: 10.1016/j.scr.2016.02.028. Epub 2016 Feb 13.
5
Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2.黄芩素通过上调 IFIT2 抑制放射和化疗耐药 MDA-MB-231 人乳腺癌细胞的干细胞样特征。
Nutrients. 2019 Mar 14;11(3):624. doi: 10.3390/nu11030624.
6
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.SLUG/SNAI2 和肿瘤坏死因子产生具有 CD44+/CD24- 表型的乳腺细胞。
BMC Cancer. 2010 Aug 6;10:411. doi: 10.1186/1471-2407-10-411.
7
Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.金属蛋白酶-解整合素ADAM12积极促进claudin低表达型乳腺癌中的干细胞样表型。
Mol Cancer. 2017 Feb 1;16(1):32. doi: 10.1186/s12943-017-0599-6.
8
SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells.SAHA克服IFIT2缺失的口腔鳞状细胞癌细胞中的5-氟尿嘧啶耐药性。
Cancers (Basel). 2020 Nov 26;12(12):3527. doi: 10.3390/cancers12123527.
9
MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.miR-21 调控第三球体形成乳腺癌干细胞样细胞中的上皮-间充质转化表型和低氧诱导因子-1α 的表达。
Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.
10
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.乳腺癌干细胞标志物 CD44、CD24 和 ALDH1:内在分子亚型内的表达分布。
J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.

引用本文的文献

1
Clinical Utility of IFIT Proteins in Human Malignancies.IFIT蛋白在人类恶性肿瘤中的临床应用
Biomedicines. 2025 Jun 11;13(6):1435. doi: 10.3390/biomedicines13061435.
2
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.IFIT3的RNA结合活性促进甲型流感病毒感染及翻译效率。
J Virol. 2025 Jul 22;99(7):e0028625. doi: 10.1128/jvi.00286-25. Epub 2025 Jun 11.
3
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.IFIT3的RNA结合活性促进甲型流感病毒感染及翻译效率。

本文引用的文献

1
Pancancer survival analysis of cancer hallmark genes.泛癌生存分析癌症标志基因。
Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5.
2
SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells.SAHA克服IFIT2缺失的口腔鳞状细胞癌细胞中的5-氟尿嘧啶耐药性。
Cancers (Basel). 2020 Nov 26;12(12):3527. doi: 10.3390/cancers12123527.
3
Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches.癌症干细胞与口腔癌:分子机制及治疗方法的见解
bioRxiv. 2025 Apr 12:2025.02.17.638785. doi: 10.1101/2025.02.17.638785.
4
The Impact of Innate Components on Viral Pathogenesis in the Neurotropic Coronavirus Encephalomyelitis Mouse Model.先天成分对嗜神经冠状病毒脑炎小鼠模型中病毒发病机制的影响。
Viruses. 2023 Dec 9;15(12):2400. doi: 10.3390/v15122400.
5
Editorial of Special Issue "Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches".《“口腔癌:从病理生理学到新型治疗方法”特刊社论》
Biomedicines. 2023 Oct 11;11(10):2748. doi: 10.3390/biomedicines11102748.
Cancer Cell Int. 2020 Apr 7;20:113. doi: 10.1186/s12935-020-01192-0. eCollection 2020.
4
Overexpression of IFIT2 inhibits the proliferation of chronic myeloid leukemia cells by regulating the BCR‑ABL/AKT/mTOR pathway.IFIT2 的过表达通过调控 BCR-ABL/AKT/mTOR 通路抑制慢性髓系白血病细胞的增殖。
Int J Mol Med. 2020 Apr;45(4):1187-1194. doi: 10.3892/ijmm.2020.4500. Epub 2020 Feb 13.
5
Emerging Functions of Human IFIT Proteins in Cancer.人源 IFIT 蛋白在癌症中的新功能
Front Mol Biosci. 2019 Dec 19;6:148. doi: 10.3389/fmolb.2019.00148. eCollection 2019.
6
Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients.人类非小细胞肺癌组织中IFIT2表达降低与癌症进展及患者不良生存相关。
Onco Targets Ther. 2019 Oct 3;12:8139-8149. doi: 10.2147/OTT.S220698. eCollection 2019.
7
Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.干扰素诱导的IFIT5促进上皮-间质转化,导致肾癌侵袭。
Am J Clin Exp Urol. 2019 Feb 18;7(1):31-45. eCollection 2019.
8
Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2.黄芩素通过上调 IFIT2 抑制放射和化疗耐药 MDA-MB-231 人乳腺癌细胞的干细胞样特征。
Nutrients. 2019 Mar 14;11(3):624. doi: 10.3390/nu11030624.
9
IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.IFIT1 和 IFIT3 通过增强 p-EGFR 回收促进口腔鳞状细胞癌转移,并有助于吉非替尼的抗肿瘤作用。
Oncogene. 2019 Apr;38(17):3232-3247. doi: 10.1038/s41388-018-0662-9. Epub 2019 Jan 9.
10
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.表型可塑性:癌症起始、进展和治疗耐药的驱动因素。
Cell Stem Cell. 2019 Jan 3;24(1):65-78. doi: 10.1016/j.stem.2018.11.011. Epub 2018 Dec 13.